Isabel T. Rubio - Concepedia

Author

Isabel T. Rubio

Vall d'Hebron Hospital Universitari ORCID

Also Known As

Escorihuela, Marta, Francesca Rovera, I Rubio, I T Rubio, I. Rubio, I. T. Rubio, I.T. Rubio, I.t. Rubio, Isabel T. Rubio, Isabel Rubio

316

Publications

12.6K

Citations

H-Index

Concepts

All Affiliations

Vall d'Hebron Hospital Universitari Universitat Autònoma de Barcelona Clinica Universidad de Navarra Champalimaud Foundation European Institute of Oncology

About

Isabel T. Rubio is an author at Vall d'Hebron Hospital Universitari specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	42	5.3K
2	Health Sciences	17	19	3.3K
3	Nursing	3	3	224
4	Engineering	2	2	173
5	Natural Sciences	1	1	49

Isabel T. Rubio

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Fátima Cardoso, S. Kyriakides, Shinji Ohno, Annals of Oncology Surgical OncologyBreast OncologyEarly Breast CancerMedicineCancer Management	2019	2.1K
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer Fátima Cardoso, Laura J. van’t Veer, Jan Bogaerts, New England Journal of Medicine	2016	2K
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition Yasir H. Ibrahim, Celina García-García, Violeta Serra, Cancer Discovery	2012	611
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer Cristina Cruz, Marta Castroviejo‐Bermejo, Sara Gutiérrez‐Enríquez, Annals of Oncology	2018	410
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program Fátima Cardoso, John M.S. Bartlett, Leen Slaets, Annals of Oncology Eortc 10085/Tbcrc/big/nabcgBreast OncologyMedicineGynecologyBreast Imaging	2017	381
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age Martine Piccart, Laura van ‘t Veer, Coralie Poncet, The Lancet Oncology Breast OncologyEarly Breast CancerMedicine70-Gene SignatureClinical Trials	2021	336
Subareolar Versus Peritumoral Injection for Location of the Sentinel Lymph Node V. Suzanne Klimberg, Isabel T. Rubio, Ronda Henry, Annals of Surgery	1999	333
A <scp>RAD</scp> 51 assay feasible in routine tumor samples calls <scp>PARP</scp> inhibitor response beyond <scp>BRCA</scp> mutation Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara, EMBO Molecular Medicine	2018	263
BRCA in breast cancer: ESMO Clinical Practice Guidelines Judith Balmañà, Isabel T. Rubio, Fátima Cardoso Annals of Oncology Breast OncologyMedicineCancer ManagementBreast CancerOncology	2011	227
BRCA in breast cancer: ESMO Clinical Practice Guidelines Judith Balmañà, Isabel T. Rubio, M. Castiglione Annals of Oncology Breast OncologyMedicineCancer ManagementBreast CancerOncology	2010	206

Page 1